Health Economics and Patient Value Real-World Evidence Forum

Real-World Evidence in the Context of Payer Decision Making and Timely Patient Access

MDIC’s Health Economics and Patient Value Real World Evidence Forum gave attendants firsthand perspectives on how CMS, commercial payers, and industry are using real world evidence to drive coverage decision making and help pave the road to patient access. This solution-focused collaboration intended to advance the understanding and practical applications of real-world evidence among Payers and Industry.

Date: April 26, 2022 | 1:00 PM (ET) – 4:00 PM (ET)

Participants collaborated, conversed and advanced their knowledge in a solution-focused environment.

Welcome and Introduction

Pamela Goldberg

MDIC Health Economics and Patient Value Overview

Jo Carol Hiatt, MD, MBA, VP, Health Economics and Patient Value, MDIC

Industry Perspective on Importance of RWE for Coverage Decision Making

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) Chief Medical Officer, Heart Failure Division, Divisional Vice President, Abbott

Recommendations for Industry from The Lewin Group Landscape Assessment

Cliff Goodman, PhD, Senior VP, The Lewin Group

Key Takeaways and Practical Considerations: Assessment of CED Over Past 15 Years

Emily Zeitler, MD, MHS, Assistant Prof of Medicine, Geisel School of Medicine, Assistant Prof of Health Care Policy, The Dartmouth Institute, Dartmouth-Hitchcock Medical Center

Considerations in Development of Transitional Coverage for Emerging Technologies (TCET)

Steve Farmer, MD, Chief Strategy Officer for Coverage at Centers for Medicare and Medicaid Services (CMS)

Commercial Payer MedTech Case Study: Opportunities for Collaboration

Debra Reisenthel, Freespira, Inc., Vice Chair, Digital Therapeutics Alliance

Eileen Rodgers, Director, Highmark VITAL Innovations Program

Panel/Roundtable Discussion


Steve Farmer, MD, CMS

Charlie Viviano, MD, PhD, FDA

Philip B. Adamson, MD, CMO, Abbott

Emily Zeitler, MD, MHA

Robert N. Cuyler, PhD, Chief Clinical Officer, Freespira, Inc.


Jo Carol Hiatt, VP, MDIC and Kimberly L. Sterling, VP, ResMed

Wrap-up and Conclusion

Jo Carol Hiatt, MD, MBA, VP, Health Economics and Patient Value, MDIC

Got questions? Contact us!